Dietary Fats and Blood Pressure: Scrutinizing an 18 mmHg Estimate

Changing the fats in your diet can support blood pressure control. It probably cannot lower systolic blood pressure by 18.43 mmHg on its own.

That number comes from a 2025 meta-analysis that reported a mean systolic blood pressure reduction of 18.43 mmHg and a diastolic reduction of 12.90 mmHg for "food-based oil diets." If true, it would rank among the largest effects reported for a dietary change. Yet the same paper estimated only a 3.83 mmHg systolic reduction for DASH, the dietary pattern with the deepest blood-pressure research base. The gap deserves more scrutiny than applause.

The eye-catching estimate has a built-in problem

Zang et al.'s 2025 systematic review and meta-analysis included 25 randomized and observational studies with 14,522 participants. It pooled several dietary-fat categories and reported lower blood pressure with unsaturated-fat patterns, smaller reductions in omega-3 categories, and little effect from restricting saturated fat.

The food-based oil subgroup produced the headline result: −18.43 mmHg systolic and −12.90 mmHg diastolic. But the available abstract does not report that subgroup's confidence interval, heterogeneity statistic, or between-study variance. Without those details, readers cannot tell how precise the estimate is, whether a few unusual studies drove it, or how much the included results disagreed.

Its DASH subgroup estimated a −3.83 mmHg systolic change. That figure fits much better with the wider intervention literature. A fivefold difference within one pooled analysis is not proof that oil-rich diets outperform DASH; it is a reason to inspect the studies, comparators, and pooling decisions behind the result.

Why dietary-fat studies are hard to interpret

Fat does not arrive at dinner alone. Replacing butter with olive oil may also change vegetables, nuts, sodium, fiber, calories, restaurant meals, and how much food someone cooks at home. In free-living people, those changes travel together.

A 2025 longitudinal study of Mexican adults examined dietary-fat substitution and blood pressure and emphasized this problem: shifts in fat intake co-occur with differences in sodium, potassium, fiber, and caloric density that statistical adjustment cannot fully separate. Such research can identify associations, but it cannot establish that one fat type alone caused the blood-pressure difference.

Pooling observational studies with randomized trials makes that problem larger. Randomization helps distribute measured and unmeasured differences between groups. Observational dietary studies instead capture many behaviors associated with oil-rich or plant-forward eating. Combining the two designs can create a precise-looking average without producing a clean answer to a causal question.

Short trials add another complication. Mediterranean-style interventions often increase vegetables alongside olive oil. Dietary nitrate from leafy greens and beets can convert to nitrite and then nitric oxide, which promotes vasodilation. A 2025 GRADE-assessed meta-analysis of 75 nitrate RCTs involving 1,823 participants found a dose-response relationship between administered nitrate and blood-pressure reductions. That does not erase a possible role for unsaturated fat, but it means a short-term blood-pressure change in an olive-oil-rich diet cannot automatically be assigned to the oil.

What stronger comparisons suggest

The broader evidence supports comprehensive dietary patterns, not a standalone fat-switching treatment. A 2024 umbrella review of diet-and-blood-pressure meta-analyses concluded that important evidence gaps remain and called for graded assessment before dietary guidance is revised. An umbrella review does not make every earlier result wrong; it does put a single dramatic subgroup estimate in its proper place.

In people with established cardiovascular disease, a 2024 network meta-analysis found dietary-pattern effects on blood pressure in the DASH-like range of roughly 3–5 mmHg systolic. These were secondary-prevention patients, where monitoring and adherence may be more structured than in many general-population studies. The analysis assessed whole patterns, so it cannot isolate fats from sodium, fiber, and food quality. Still, its scale is consistent with Zang et al.'s DASH estimate and inconsistent with assigning an 18.43 mmHg reduction to food-based oils alone.

A 2025 meta-analysis of randomized trials comparing Mediterranean diets supplemented with olive oil or mixed nuts offers a more controlled analog to an oil-focused dietary intervention. It also evaluates diet patterns rather than purified fat effects, which is the central practical reality: people change meals, not isolated fatty acids.

Real-world follow-up points in the same direction. A 12-month intervention in 84 people with type 2 diabetes and hypertension compared a Mediterranean-DASH dietary approach with no dietary changes. Its clinical setting and longer follow-up make it useful context for what sustained pattern change can achieve, though its correlational analyses cannot prove that any single nutrient caused its blood-pressure outcomes.

Omega-3s have a plausible role, with a dose caveat

Omega-3 polyunsaturated fats are the clearest candidate for a fat-specific blood-pressure effect, but the effect appears modest and depends on dose and baseline status. Whole-food sources improve fatty-acid exposure without necessarily matching supplement-trial doses.

For example, a four-week randomized trial in 34 healthy adults found that grass-finished lamb increased plasma omega-3 fatty-acid response compared with concentrate-finished lamb. The participants ate two portions of chops and one portion of mince weekly. This was a biomarker finding, not a blood-pressure result, so it supports biological plausibility rather than proving an antihypertensive effect.

That distinction matters when meta-analyses combine low-dose whole-food exposure with higher-dose supplement trials. A pooled omega-3 estimate may not tell a reader what one extra serving of fish, lamb, or walnuts will do to their blood pressure.

Saturated and trans fats matter for a different reason

Zang et al. found minimal blood-pressure effect from restricting saturated fat. That result does not make saturated fat harmless. The cardiovascular rationale for reducing it centers largely on lipoprotein metabolism and LDL-related atherosclerotic risk, not a direct effect on vascular tone or kidney sodium handling. Replacing saturated fat with refined carbohydrates also does not preserve the expected cardiovascular benefit.

Eliminating industrial trans fats remains justified because of their atherogenic effects. Blood pressure is not the main endpoint that makes trans-fat removal worthwhile. A 2024 cross-sectional study of 151 long-term plant-based eaters likewise illustrates the interpretive limit: dietary-fat patterns track with many other features of a whole-food diet, so associations with cardiovascular risk factors cannot identify fat as the sole driver.

The practical verdict

Use unsaturated fats as part of a Mediterranean or DASH-style diet, but treat an 18.43 mmHg oil-diet claim as an uncertain subgroup estimate, not a personal forecast.

Replace trans fats and much of the saturated fat in your diet with foods rich in monounsaturated and polyunsaturated fats: olive oil, nuts, seeds, fish, and other minimally processed foods. Pair that change with vegetables, adequate potassium-rich foods when medically appropriate, and moderate sodium intake. The package matters more than a single pour of oil.

For hypertensive adults, a roughly 3–5 mmHg systolic improvement is a realistic optimistic expectation for broad dietary-pattern change. That can matter at a population level and alongside other treatment. It is not a substitute for medical care when blood pressure needs to fall by 15 mmHg or more. The 18.43 mmHg result may reflect a real signal mixed with design differences and confounding; the published information does not support treating it as a settled fat-specific effect.